FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1146.2663.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1146.2663/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2663 |
| Version | 20250621 |
| Status | active |
| Date | 2025-06-21T01:03:03-04:00 |
| Name | AmikacinRXNORM |
| Title | Amikacin (RXNORM) |
| Realm | us |
| Authority | hl7 |
| Description | All prescribable medication formulations represented using either a "generic" or "brand-specific" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), or BPCK (brand pack). SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set. |
| Purpose | (Clinical Focus: This set of values contains codes for prescribable medications for Amikacin),(Data Element Scope: medications that were administered, ordered or prescribed.),(Inclusion Criteria: Amikacin),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1146.2663",
"meta": {
"versionId": "8",
"lastUpdated": "2025-06-21T01:03:03.000-04:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "CSTE Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
"valueString": "G_Common,Meds"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-06-21"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2025-06-21"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.2663",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1146.2663"
}
],
"version": "20250621",
"name": "AmikacinRXNORM",
"title": "Amikacin (RXNORM)",
"status": "active",
"date": "2025-06-21T01:03:03-04:00",
"publisher": "CSTE Steward",
"description": "All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), SBD (semantic brand drug), GPCK (generic pack), or BPCK (brand pack).\nSCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This set of values contains codes for prescribable medications for Amikacin),(Data Element Scope: medications that were administered, ordered or prescribed.),(Inclusion Criteria: Amikacin),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1598047",
"display": "amikacin 250 MG/ML Injectable Solution"
},
{
"code": "1723156",
"display": "2 ML amikacin 250 MG/ML Injection"
},
{
"code": "1723160",
"display": "4 ML amikacin 250 MG/ML Injection"
},
{
"code": "2059184",
"display": "amikacin liposomal 70.3 MG/ML Inhalation Suspension"
},
{
"code": "2059189",
"display": "amikacin liposomal 70.3 MG/ML Inhalation Suspension [Arikayce]"
},
{
"code": "905148",
"display": "amikacin sulfate 50 MG/ML Injectable Solution"
},
{
"code": "905156",
"display": "amikacin sulfate 5 MG/ML Injectable Solution"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:2d5037e8-410c-4e14-b272-577bbaeb36eb",
"timestamp": "2025-11-24T13:33:26-05:00",
"total": 7,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "1598047",
"display": "amikacin 250 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "1723156",
"display": "2 ML amikacin 250 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "1723160",
"display": "4 ML amikacin 250 MG/ML Injection"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "2059184",
"display": "amikacin liposomal 70.3 MG/ML Inhalation Suspension"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "2059189",
"display": "amikacin liposomal 70.3 MG/ML Inhalation Suspension [Arikayce]"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "905148",
"display": "amikacin sulfate 50 MG/ML Injectable Solution"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "09022025",
"code": "905156",
"display": "amikacin sulfate 5 MG/ML Injectable Solution"
}
]
}
}